5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinamide, 96.0%, 1g

Isobutyronitrile, 98.0%, 25g

1-(4-Chloro-2-methoxyphenyl)ethan-1-one, 97%, 10g

ethyl 5-oxo-1-(propan-2-yl)-2,5-dihydro-1H-pyrazole-3-carboxylate, 95+%, 250mg

1-(5-BROMOPYRIDIN-2-YL)ETHANAMINE HCL, 95.0%, 1g

(S,S)-(+)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine, 95.0%, 1g

N-(4-Fluorophenethyl)-4-(4-methyl-7-oxo-2-(p-tolyl)-2H-pyrazolo[3,4-d]pyridazin-6(7H)-yl)butanamide, 98.0%, 100mg

5-(3-METHYLPHENYL)-1H-TETRAZOLE, 95%, 5g

5-Bromo-2-methyl-8-nitro-1,2,3,4-tetrahydroisoquinoline, 95.0%, 5g

Reattori per sintesi peptidica, 2 ml, 10 pezzi, 10 pezzi

5-Chloro-2-fluorobenzyl bromide, 98.0%, 100g

(1R,2S)-Cyclobutane-1,2-dicarboxylic acid, 97.0%, 10g

Acido succinico, minimo 99%, per sintesi, , 2,5 kg, confezione in plastica.